✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

Haemonetics Corp

Common Name
Haemonetics
Country
United States
Sector
Healthcare
Industry
Medical Devices
Employees
3,023
Ticker
HAE
Exchange
NEW YORK STOCK EXCHANGE, INC.
Description
Haemonetics Corporation is a global healthcare company dedicated to providing innovative blood management solutions for organizations around the world. The company plays a crucial role in the healthca...

Haemonetics's Financial Statements Preview

Below are the financial statements of Haemonetics, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024
2023
2022
Net revenues
1,309.06a
1,168.66a
993.2a
Cost of goods sold
-617.51a
-553.56a
-487.69a
Gross profit
691.55a
615.1a
505.5a
Operating expenses
Research and development
-54.44a
-50.13a
-46.8a
Selling, general and administrative
-431.78a
-376.68a
-340.14a
Amortization of acquired intangible assets
-32.03a
-32.64a
-47.41a
Gains on divestiture and sale of assets
-2a
-0.38a
-9.6a
Impairment of intangible assets
-10.42a
0a
0a
Total operating expenses
-526.67a
-459.06a
-424.75a
Operating income
164.88a
156.03a
80.75a
Interest and other expense, net
-13.02a
-14.63a
-17.12a
Income before provision for income taxes
151.87a
141.4a
63.63a
Provision for income taxes
-34.31a
-26a
-20.25a
Net income
117.56a
115.4a
43.38a
Limited Data Preview
You are viewing a limited preview of Haemonetics’s income statement data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Unrestricted Access to Data and Sources
pro
Remove manual data sourcing from your workflow. Upgrade to Tracenable Pro for unrestricted access to datasets and disclosures across 8,500+ companies with over 10 years of historical coverage.
Download complete datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace values back to original sources
Formats Included
Excel
CSV
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Haemonetics’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Haemonetics’s data sources below and access millions more through our Disclosure Search.

a. Haemonetics's 10-K 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?